skip to Main Content

GALLERY

Stories: “Heparin can still surprise us”

Despite being a centenary drug, heparin remains as one of the essential drugs of medicine and especially of modern surgery but (…)

Short story: Dr. Castillon fights against complicated pregnancies

Main character of the documentary: “Heparin, 100 years saving lives”

Stories: “As soon as I found I was pregnant, I started getting heparin shots”

The use of heparin in pregnancy is increasingly common to avoid thromboembolic complications, abortions or delays (…)

Stories- “Producing heparin is a satisfaction and a responsibility”

Since its foundation in 1975, Bioiberica has been focused on the production of heparin.
The company understood that (…)

Stories- Sport and thrombosis: a real story

Although they may appear immune to thrombosis due to their physical training, athletes are not risk free. In this story we’ll meet (…)

Short story: Dr. Guerrini investigates the use of heparin as an antitumoral treatment.

Main character of the documentary: “Heparin, 100 years saving lives”

Stories: Who discovered Heparin?

Who discovered Heparin? Was it Jay McLean, the student? Or was it its teacher, William Howell? What is clear is that, 100 years ago (…)

Stories: Heparin as a new strategy to fight malaria?

The Catalan Institute of Bioengineering, the Barcelona Institute of Global Health and Bioibérica have joined forces to study the development (…)

Stories: A lifetime dedicated to research

Professor Hemker has published over 400 research papers on Haemostasis and Thrombosis and has also dedicated his (…)

Short story: Dr. Ramon Salinas, director of the Blood and Tissue Bank

Main character of the documentary: “Heparin, 100 years saving lives”

Short story: James Marcum, medical historian

Main character of the documentary: “Heparin, 100 years saving lives”.

Short story: Dr. Joan Carles Souto, hematologist

Main character of the documentary: “Heparin, 100 years saving lives”

Stories- A case of thrombosis in pregnancy

It is estimated that one or two women in a thousand may have thrombosis during pregnancy. In fact, gestation increases (…)

Interview with Zachary Shriver, Harvard-MIT Division of Health Sciences & Technology

Late September 2016, leading glycosaminoglycan specialists convened to discuss the future of Heparin at the (…)

Short story: Dr. Bernardo Romero, cardiovascular surgeon

Main character of the documentary: “Heparin, 100 years saving lives”

Documentary: “Heparin: 100 years saving lives”

“Everybody has heard of penicillin, but nobody knows what heparin is. And the fact is that heparin has saved as many lives as penicillin (…)

Stories: A look to the future of heparin

100 international participants gathered and the focus of debate centered on a single molecule: heparin. Late last year, leading (…)

Documentary Trailer “Heparin: 100 years saving lives”

After nearly a year of filming, we can finally present a preview of the documentary on the 100th anniversary of the discovery (…)

Scientific lecture: “Past, present and future of heparin”

The International Society on Thrombosis and Hemostasis (ISTH) celebrated its annual meeting in Montpellier and devoted the cultural (…)

What is the difference between a blood clot and a thrombus?

A clot is good when there is damage to the vascular tissue, but it is dangerous if it forms in a healthy blood vessel. In this (…)

Full event: Celebration of Heparin’s Centenary

The centenary of the discovery of heparin was celebrated in Madrid on 17th June 2016 with an event sponsored by (…)

A tribute to Heparin

Heparin is the most commonly used anticoagulant and antithrombotic in the world and today appears on the World Health (…)

Stories: “I have a baby thanks to heparin”

Heparin saves millions of lives every year. And an example is that of Monica, who managed to complete her third pregnancy with (…)

Stories: 40 years of leadership in the production of heparin

Bioibérica was founded in 1975 and its first product was heparin. 40 years later, this biotech company has become a world leader (…)

Stories: “Heparin saved my life”

Pain, swelling, local heat… Andrew Schorr is an American living in Barcelona, who was diagnosed with two blood clots in his legs. (…)

INDUSTRIAL CENTER

C/ Antic Camí de la Tordera, 109-119
08389 Palafolls (Barcelona)
Tel: +34 93 765 03 90
Fax: +34 93 765 01 02

CORPORATE OFFICES

Plaza Francesc Macià, 7
08029 Barcelona
Tel: +34 93 490 49 08
Fax: +34 93 490 97 11

CONTACT WITH US

CONTACT US

Name and Surname:
Email:
Company:
Country:
Message:
I agree to the privacy policy.

© 2019. Bioiberica S.A.U. All rights reserved

INDUSTRIAL CENTER

C/ Antic Camí de la Tordera, 109-119
08389 Palafolls (Barcelona)
Tel: +34 93 765 03 90
Fax: +34 93 765 01 02

CONTACT WITH US

CONTACT US

Name and Surname:
Email:
Company:
Country:
Message:
I agree to the privacy policy.

CORPORATE OFFICES

Plaza Francesc Macià, 7
08029 Barcelona
Tel: +34 93 490 49 08
Fax: +34 93 490 97 11

© 2019. Bioiberica S.A.U. All rights reserved

INDUSTRIAL CENTER

C/ Antic Camí de la Tordera, 109-119
08389 Palafolls (Barcelona)
Tel: +34 93 765 03 90
Fax: +34 93 765 01 02

CORPORATE OFFICES

Plaza Francesc Macià, 7
08029 Barcelona
Tel: +34 93 490 49 08
Fax: +34 93 490 97 11

CONTACT WITH US

CONTACT US

Name and Surname:
Email:
Company:
Country:
Message:
I agree to the privacy policy.

© 2019. Bioiberica S.A.U. All rights reserved

You are about to access information on our medicines and medical devices aimed exclusively at healthcare professionals.

By virtue of Spanish Royal Decree 1416/1994 of 25 June regulating the advertising of medicinal products for human use, Spanish Royal Decree 1591/2009 of 16 October regulating medical devices and Law 29/2006 of 26 July on the guarantees and rational use of medicines and health products, in this section Bioibérica can only offer advertising content of prescription medicines to health personnel authorised to prescribe or dispense them.

I am a health professional authorised to prescribe or dispense, or a pharma company professional.

You must be a health professional
authorised to acces this page.
Back To Top